Date updated:12-22-2008
“Kinetics Medical Fund seeks long-term growth of capital. The Fund normally invests at least 80% of its total assets in common stocks, convertible securities, warrants and other securities such as ADRs and IDRs of U.S. and foreign companies engaged in the medical research, generally, with an emphasis toward companies engaged in cancer research and drug development. It may also invest up to 20% of its total assets in convertible and nonconvertible debt securities below investment grade, or unrated securities, which the investment adviser has determined to be of comparable quality. The Fund is non-diversified.”
Official Website
The fund has had an average annual return of 2.94 % over the last five years, significantly beating the S&P 500 over the same period.

-
WYE
Wyeth - $48.54
- 0.00%
- $N/A
No Analysis added

-
NVS
Novartis Ag Ads - $55.78
- +0.02%
- $56.36
No Analysis added

-
GSK
Glaxosmithkline P - $42.44
- +0.14%
- $42.60
No Analysis added

-
GENZ
Genzyme Corporati - $50.27
- -1.99%
- $51.75
No Analysis added

-
IVGN
N/a - $24.76
- 0.00
- $24.76
No Analysis added

-
ABT
Abbott Laboratori - $54.24
- -0.37%
- $54.41
No Analysis added

-
BIIB
Biogen Idec Inc - $47.38
- -0.75%
- $47.50
No Analysis added

-
JNJ
Johnson And Johns - $64.16
- +0.44%
- $64.05
No Analysis added
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Robert Karr - Joho Cap...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Fred Fuld Posted on Dec. 3, 2009 Everyone can appreciate the security offered by a regular income, whether in the form of a paycheck or retirement check -- or a divi...
Posted on Dec. 3, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is to gather as much in...
By Roberto Pedone Posted on Dec. 3, 2009 The traders of CNBC’s “Fast Money” think the path of least resistance for the stock market remains to the upside. On Tues...
Posted on Dec. 2, 2009 Not a Stockpickr member? Join the community today -- for free. Regardless of why a stock is in the news, it never hurts to hear what a professi...
A. The only one I own : SLX,
too hard pick a winner out all of them
TheStreet Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its "safety first" approach to investing a... more
Here are some of the biggest stocks that made the 52-week high list on Dec. 3, 2009. more
Here are the 10 stocks in the Dow Jones Industrial Average stocks with the highest yields as of the market close on Dec. 3, 2009. more













Comments not available